top of page
Slide 99.png

Pioneering the ‘omics era of cell physiology

Fluxion

AI-powered drug decisions from live cell signals

Omics gave us snapshots. 
But real-time cell behavior was missing. We unlock it.

Group

We call it Physiomics

Physiomics is a new field of biotech focused on capturing dynamic cell activity in real time—through automated electrical recordings and AI analysis.

why it matters

A missing layer in drug R&D

Unlocks functional, time-based insights no static assay can provide

We welcome alpha- users for our ScorpION© Automated Patch-Clamp QC and Analytics tool.

ScorpION© provides automated QC and basic analytics for ion channel patch-clamp datasets. “We apply a combination of 4 ML models: Elliptical Distance Model, Margin-Based Boundary, Unsupervised Random Forest, and Local Outlier Factor - in developing our 1st iteration of a QC module capable of learning relevant QC parameters from existing and synthetic datasets, and apply those to new data streams” - Ilia Buianov, Chief Data Officer.

Fluxion seeks co-development partners interested in early access to ScorpION©. Please reach out to BD@flxion.ai.

This is our first video demonstration of the ScorpION© early capabilities: it allows for the 384 well sweep visualizations, automated QC and basic ephys parameters calculations. It works with 384 Synchropatch and Qube outputs as well as the manual recordings.

Instead of evaluating a single-parameter assay, 
we record dynamic cell response

snapshot
With 1 ion channel

• One binary answer: open or closed

• One data point

• Limited resolution

Open

/

Closed
FROM A
snapshot TO
A MOVIE
movie

full dynamic profile:

OPENING SPEED
RESPONSE STRENGTH
OPEN DURATION

Dozens of features per channel

 Rich, multi-dimensional insight

Group

We’re building the next 'omics' layer for drug R&D

We bring AI to bioelectricity

20251224-1pager
12

Built by experts in electrophysiology, AI, and drug development

Ilya (Eli) Kovalenko-profile-1.png
Eli Black

PhD, CEO

Leads scientific vision, coordinates product development, and drives integration of AI into assays. 15+ years in life sciences. Coined the term ‘AIDD’ in 2018.

RMD-1.png
Ron Demuth

PhD, COO, Chairman

Owns strategy, operations, and execution. Oversees partnerships and execution; relentless biotech founder/ exec/investor with $10M→$75M scale record, multiple exits.

Ilia Buianov-Profile.png
Ilia Buianov

PhD, CDataO

Owns model architecture, data strategy, and AI development. Background in applied math, biophysics, and computer vision.

Contact us

Tell us about yourself so we can connect you to the right person.

Area of Interest
Position
Are you interested in helping us to grow the ScorpION (sharing datasets with us)?
Yes
No
Which data type you want to analyse:
bottom of page